Skip to main navigation Skip to search Skip to main content

Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4α2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed

  • Nathan L. Absalom
  • , Gracia Quek
  • , Trevor M. Lewis
  • , Taima Qudah
  • , Ida Von Arenstorff
  • , Joseph I. Ambrus
  • , Kasper Harpsøe
  • , Nasiara Karim
  • , Thomas Balle
  • , Malcolm D. McLeod
  • , Mary Chebib
  • The University of Sydney
  • University of New South Wales
  • Australian National University
  • University of Copenhagen

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

Background: Methyllycaconitine is an antagonist at subtypes of the nicotinic acetylcholine receptor. Results: A reactive methyllycaconitine probe was covalently trapped by a cysteine introduced on the complementary face of the α4 subunit and only in the (α4)3(β2)2 nAChR stoichiometry. Conclusion: The α4-α4 interface on the α4β2 nAChR contains a methyllycaconitine binding site. Significance: Defining the molecular interactions of nAChR ligands at the α4-α interface may lead to superior therapeutics.

Original languageEnglish
Pages (from-to)26521-26532
Number of pages12
JournalThe Journal of Biological Chemistry
Volume288
Issue number37
DOIs
Publication statusPublished - 13 Sept 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4α2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed'. Together they form a unique fingerprint.

Cite this